Home > Cashflow Statement > MARKSANS PHARMA

MARKSANS PHARMA
Cashflow Statement

MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹504 Cr₹424 Cr₹338 Cr₹248 Cr₹302 Cr
Adjustment ₹69 Cr₹55 Cr₹74 Cr₹35 Cr₹57 Cr
Changes In working Capital ₹-241 Cr₹-126 Cr₹-111 Cr₹-111 Cr₹-132 Cr
Cash Flow after changes in Working Capital ₹333 Cr₹353 Cr₹300 Cr₹172 Cr₹227 Cr
Cash Flow from Operating Activities ₹207 Cr₹230 Cr₹237 Cr₹99 Cr₹179 Cr
Cash Flow from Investing Activities ₹-49 Cr₹-141 Cr₹-259 Cr₹-84 Cr₹-45 Cr
Cash Flow from Financing Activities ₹-65 Cr₹-69 Cr₹198 Cr₹80 Cr₹-15 Cr
Net Cash Inflow / Outflow ₹93 Cr₹21 Cr₹176 Cr₹94 Cr₹118 Cr
Opening Cash & Cash Equivalents ₹403 Cr₹382 Cr₹206 Cr₹112 Cr₹94 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations --₹0.00 Cr--
Closing Cash & Cash Equivalent ₹496 Cr₹403 Cr₹382 Cr₹206 Cr₹212 Cr

Compare Cashflow Statement of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹7,806.4 Cr -1% -8% -30.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,497.0 Cr -3.5% -6.4% -2.6% Stock Analytics
DIVIS LABORATORIES ₹165,492.0 Cr -5.8% -1.6% 10.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,013.0 Cr 1.4% 7% 23.7% Stock Analytics
CIPLA ₹112,922.0 Cr -4.7% -6.8% -0.3% Stock Analytics
DR REDDYS LABORATORIES ₹98,115.0 Cr -2.8% -8.1% -11.1% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-1%

-8%

-30.6%

SENSEX

-0.7%

-1.9%

8%


You may also like the below Video Courses